GLPwatch
Trials (2139)
Page 2 of 36.
- Post-Marketing Surveillance Study: 12 To 24 Weeks Study On The Treatment Emergent Adverse Events In Patients With Type 2 Diabetes Taking Exenatide In Korea
- RISE Adult Medication Study
- A Study to Examine the Pharmacokinetics, Tolerability, Safety and Efficacy of Exenatide Once Weekly Suspension
- Effect of Weekly GLP1 Agonist Treatment in "Double Diabetes"
- A Study to Test Safety and Efficacy of Survodutide (BI456906) in Adults With Non-alcoholic Steatohepatitis (NASH) and Fibrosis (F1-F3)
- A Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7204239 in Combination With Tirzepatide in Participants With Obesity or Overweight With At Least One Weight-related Comorbidity
- PATHS-T2D: A Recall-by-Genotype Study of Physiologic and Pharmacologic Responses
- Effect of Tirzepatide on Markers of MASLD in Patients With Obesity
- Impact of Bariatric Surgery and Liraglutide on Cognitive-Behavioral Markers of Long-Term Weight Loss in Obesity
- The Study of Exenatide Action on Vessel Function in Type 2 Diabetes and Prediabetes
- Safety, Tolerability and Pharmacokinetics of a Subcutaneous Semaglutide Implant
- Real World Effectiveness of Oral Semaglutide in Thailand Participants With Type 2 Diabetes
- Effect of Exenatide on Cortisol Secretion
- A Trial to Investigate the Safety and Efficacy of Intra-articular 4P004 Injection in Subjects With Knee Synovitis and Osteoarthritis
- Phase 1 Study Assessing the Pharmacokinetics of NEX-22A in Subjects With T2D
- Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant
- A Study to Test Whether Different Doses of BI 456906 Help People With Overweight or Obesity to Lose Weight
- The Effect of Liraglutide on the Treatment of Coronary Artery Disease and Type 2 Diabetes
- Characteristics and Treatment Experiences of Individuals Using Injectable Semaglutide for Weight Management, a Cross-sectional Time-series Analysis, Multi-country Study.
- Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of JY09
- The Effect of Soliqua on Glucose Variability in Type 2 Patients Among South Asians
- Urinary Proteomics to Guide Early Intervention to Prevent Complications in Type 2 Diabetes - a Feasibility Study
- Islet Transplantation in Type 1 Diabetic Patients Using the Edmonton Protocol of Steroid Free Immunosuppression
- Effect of Soliqua 100/33 on Time in Range From Continuous Glucose Monitoring in Insulin-naive Patients With Very Uncontrolled Type 2 Diabetes Mellitus
- A Study of Tirzepatide (LY3298176) in Adult Participants in India With Either Type 2 Diabetes Mellitus or Obesity
- A Study to Assess the Effect of Exenatide Treatment on Mean 24-Hour Heart Rate in Patients With Type 2 Diabetes
- The Impact of Semaglutide Compared to Energy Restriction on Type 2 Diabetes
- A Research Study to See How Well CagriSema Helps People in China With Excess Body Weight Lose Weight
- Glucagon-like Peptide-1 Receptor Agnoists for the Assessment of Adrenal Function
- Safety and Efficacy of Liraglutide in Combination With an OAD in Subjects With Type 2 Diabetes Insufficiently Controlled on OAD Alone
- Incretin-based Therapy in Late Preclinical Type 1 Diabetes
- Menopausal Hormone Therapy, GLP-1 Agonists, and Glucose and Energy Homeostasis in Postmenopausal Women With Diabetes
- Exenatide for Myocardial Protection During Reperfusion Study
- Treating PCOS With Semaglutide vs Active Lifestyle Intervention
- A Research Study to Compare a New Medicine Oral Semaglutide to a Dummy Medicine in Children and Teenagers With Type 2 Diabetes
- Evaluation of Gastric Content of Volunteers Fasting and Using Semaglutide: an Observational and Cross-sectional Study
- Impact of Using a GLP1 on Treatment Related Side Effects of Lung Cancer Patients Receiving Lorlatinib
- A Study Looking at How Weekly Injections of Two Hormones - GIP and Amylin - Affect Stomach-related Side Effects in People Who Are Overweight or Obese
- Effect of Lixisenatide on Postprandial Plasma Glucose Compared to Sitagliptin in Combination With Insulin Glargine
- A Study of Cotadutide in Participants Who Have Chronic Kidney Disease With Type 2 Diabetes Mellitus
- An Exploratory Study of the Effect of Treatment Interruption on Safety of Exenatide in Patients With Type 2 Diabetes
- Repurposing Semaglutide for the Treatment of Cocaine Use Disorder
- GLP1-RAs Effects on Inflammatory and Endothelial Biomarkers in T2DM
- A Research Study Looking at How Well a Combination of the Medicines Semaglutide and NNC0480-0389 Works in People With Type 2 Diabetes
- To Predict Weight Loss Response to Liraglutide (Saxenda®), From fMRI-based Determination of Food Cue Reactivity
- A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar
- Multiple Dose Trial Examining Dose Range, Escalation and Efficacy of Oral Semaglutide in Subjects With Type 2 Diabetes
- A Clincial Study Testing Tirzepatide on Reproductive Function and Metabolic Health in Women With PCOS Who Are Overweight or Obese
- A Research Study to Look Into How Well Semaglutide Medicine Works at Different Doses in People With Type 2 Diabetes and Overweight
- Efficacy and Safety of Semaglutide Ingection in Subjects With Type 2 Diabetes
- GLP-1 RA for Stage 1 Type 1 Diabetes
- A Study of Tirzepatide (LY3298176) in Healthy Participants and Participants With Type 2 Diabetes (T2DM)
- Comprehensive Clinical Evaluation Study of GLP-1RA
- Tirzepatide Following Adrenalectomy in Mild Autonomous Cortisol Secretion
- A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
- CRAVE Study: Comparing Craving Responses and Diet Quality of GLP1 Receptor Agonist Users
- Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility Study
- Evaluating Liraglutide in Alzheimer's Disease
- Postprandial Glucodynamic Response to Insulin Glargine/Lixisenatide Fixed Ratio Combination in Japanese Patients With Type 2 Diabetes Mellitus
- Exenatide and Brown Adipose Tissue